Company: ZCARW
Filing Date: 2025-03-04
Form Type: S-1
Source: 0001213900-25-020176
Chunk: 43

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-04
Form: S-1
Chunk 43
---
 Offering to purchase up to an aggregate of 12,429,232 shares of Common Stock at an exercise price of $0.806 per share; and January/February Series B Warrants and December Placement Agent Series B Warrants for a maximum of 8,445,903 shares of Common Stock at an exercise price of $0.0001 per share 21 Additionally, If the December Series A Warrants are reset or ratcheted down to their respective Floor Prices, then there would be (in each case subject to rounding) (i) December Series A Warrants to purchase 52,493,766 shares of Common Stock at an exercise price of $0.312 per share, (ii) December Placement Agent Common Warrants to purchase 2,197,456 shares at an exercise price of $0.312 per share and (iii) December Placement Agent Series A Warrants to purchase 5,425,275 shares at an exercise price of $0.312 per share. Further, If the January/February Series A Warrants are reset or ratcheted down to their respective Floor Prices, then there would be (in each case subject to rounding) (i) January/February Series A Warrants to purchase 30,028,071 shares of Common Stock at an exercise price of $0.312 per share, (ii) January/February Placement Agent Common Warrants to purchase 960,900 shares at an exercise price of $0.312 per share and (iii) January/February Placement Agent Series A warrants to purchase 3,002,814 shares at an exercise price of $0.312 per share. Further, all the warrants issued in the November Offering, December Offering and January/February/Offering contain reset provisions and full ratchet anti-dilution protection described elsewhere herein. Because the market for our Common Stock is thinly traded, the sales and/or the perception that those sales may occur, could adversely affect the market price of our Common Stock. Furthermore, even though the options and warrants (other than the warrants issued in June 2024, November Pre-Funded Warrants, the November Series B Warrants, the December Pre-Funded Warrants, the December Series B Warrants, the January/February Pre-Funded Warrants and the January/February Series B Warrants) are all out of the money, the mere existence of a significant number of shares of Common Stock issuable upon exercise of these securities may be perceived by the market as having a potential dilutive effect, which